HMGB1 serum levels as a potential new biomarker of disease severity in recessive dystrophic epidermolysis bullosa

被引：0
|
作者：
Petrof, G. [1 ]
McGrath, J. [1 ]
机构：
[1] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2012年 / 166卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：e38 / e38
页数：1
相关论文
共 50 条
  • [31] CORRELATION BETWEEN SERUM LEVELS OF HMGB1 AND A? WITH DISEASE SEVERITY IN PATIENTS WITH ACUTE ISCHEMIC STROKE
    Zhong, Jieping
    Qin, Lianhua
    Zhang, Yiling
    Zhang, Yanan
    ACTA MEDICA MEDITERRANEA, 2023, 39 (01): : 299 - 304
  • [32] Endoscopic dilatation of esophageal strictures in recessive dystrophic epidermolysis bullosa: New equipment, new techniques
    Kay, M
    Wyllie, R
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002, 34 (05): : 515 - 518
  • [33] Molecular basis of recessive dystrophic epidermolysis bullosa: Genotype/phenotype correlation in a case of moderate clinical severity
    Shimizu, H
    McGrath, JA
    Christiano, AM
    Nishikawa, T
    Uitto, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (01) : 119 - 124
  • [34] A COL7A1 variant leading to in-frame skipping of exon 15 attenuates disease severity in recessive dystrophic epidermolysis bullosa
    Schwieger-Briel, A.
    Weibel, L.
    Chmel, N.
    Lepert, J.
    Kernland-Lang, K.
    Grueninger, G.
    Has, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (05) : 1308 - 1311
  • [35] Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity
    Odorisio, Teresa
    Di Salvio, Michela
    Orecchia, Angela
    Di Zenzo, Giovanni
    Piccinni, Eugenia
    Cianfarani, Francesca
    Travaglione, Antonella
    Uva, Paolo
    Bellei, Barbara
    Conti, Andrea
    Zambruno, Giovanna
    Castiglia, Daniele
    HUMAN MOLECULAR GENETICS, 2014, 23 (15) : 3907 - 3922
  • [36] A comparison of Type VII collagen levels, mmp1 promoter polymorphism and clinical severity in a Mexican cohort of patients with recessive dystrophic epidermolysis bullosa
    Garza-Gomez, J.
    Salas-Alanis, J.
    Ocampo-Candiani, J.
    Gomez-Flores, M.
    McGrath, J.
    South, A. P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S92 - S92
  • [37] Persistent elevation of serum interleukin-6 and serum amyloid Alevels in patients with recessive dystrophic epidermolysis bullosa
    Morizane, Shin
    Mizuno, Kazuko
    Takiguchi, Tetsuya
    Ogita, Satoko
    Nishida, Yoshinobu
    Kawakami, Yoshio
    Iwatsuki, Keiji
    EUROPEAN JOURNAL OF DERMATOLOGY, 2017, 27 (01) : 80 - 81
  • [38] Bone marrow-derived MSCs show therapeutic potential for recessive dystrophic epidermolysis bullosa
    Ganier, C.
    Titeux, M.
    Gaucher, S.
    Peltzer, J.
    Portier, S.
    Lataillade, J.
    Hovnanian, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S190 - S190
  • [39] Thrombospondin 1 is a major activator of TGF-beta in Recessive Dystrophic Epidermolysis Bullosa
    Atanasova, V. S.
    Russell, R.
    Webster, T. G.
    Salas, J.
    South, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S307 - S307
  • [40] Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa
    Petrof, Gabriela
    Lwin, Su M.
    Martinez-Queipo, Magdalena
    Abdul-Wahab, Alya
    Tso, Simon
    Mellerio, Jemima E.
    Slaper-Cortenbach, Ineke
    Boelens, Jaap J.
    Tolar, Jakub
    Veys, Paul
    Ofuya, Mercy
    Peacock, Janet L.
    Martinez, Anna E.
    McGrath, John A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (09) : 2319 - 2321
12345